Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
EPS (Diluted)
Modalis Therapeutics Corp
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Modalis Therapeutics Corp
TSE:4883
|
EPS (Diluted)
-¥77
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
EPS (Diluted)
¥165
|
CAGR 3-Years
81%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
EPS (Diluted)
¥23
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
EPS (Diluted)
¥12
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
0%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
EPS (Diluted)
¥165
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
38%
|
|
S
|
StemRIM Inc
TSE:4599
|
EPS (Diluted)
¥2
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's EPS (Diluted)?
EPS (Diluted)
-77.2
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's EPS (Diluted) amounts to -77.2 JPY.
What is Modalis Therapeutics Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-48%
Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for Modalis Therapeutics Corp have been -66% over the past three years , -48% over the past five years .